Resource Hub

Oncology Cell & Gene Therapy: Market Snapshot
Oncology Cell & Gene Therapy: Market Snapshot
CAR-T has long been the dominant force in cell and gene therapy, but understanding just how dominant, and what that means for the rest of the oncology CGT landscape, requires more than a headline. Kalorama’s latest market data breaks down the oncology cell and gene therapy market by product type, revealing a competitive picture that has real implications for pipeline strategy, investment decisions, and market positioning.
Why Download This Asset:
– Understand the current market distribution across CAR-T, cell immunotherapy, gene/RNA therapy, and other product types
– See which segments hold the most ground — and where emerging approaches are carving out space
– Benchmark the competitive landscape as in vivo CAR-T investment accelerates and the market prepares for its next evolution
– Ground your strategy in Kalorama data drawn from the most comprehensive CGT market report available


